Description
Composition- Linagliptin 5 mg + Metformin 500 mg Extended Release
Mode of Action- Enhances incretin action while providing sustained metformin support to improve glycemic control throughout the day.
USPs- Dual antidiabetic mechanism; extended-release metformin benefit; better compliance and glycemic stability.
Prescribing Specialties- Diabetologist, General Physician
